Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 759-765

  Fox, D G ^a   Balfe, P ^b   Palmer, C P ^a   May, J C ^b   Arnold, C ^c   McKeating, J A ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN GLYCOSYLATION; SERUM; T LYMPHOCYTE; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

EID: 0031060154     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.759-765.1997     Document Type: Article

References (64)

1. Alkhatib, G. C., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC-CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage tropic HIV-1. Science 272:1955-1958.
2. Andeweg, A. C., P. H. M. Boers, A. D. M. E. Osterhaus, and M. L. Bosch. 1995. Impact of natural sequence variation in the V2 region of the envelope protein of human immunodeficiency virus type-1 on syncytium induction - a mutational analysis. J. Gen. Virol. 76:1901-1907.
3. Andeweg, A. C., P. Leeflang, A. D. M. E. Osterhaus, and M. L. Bosch. 1993. Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation. J. Virol. 67:3232-3239.
4. Asjo, B., L. Morfeldt-Manson, J. Albert, G. Biberfeld, A. Karlsson, K. Lidman, and E. M. Fenyo. 1986. Replicative properties of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet ii:660-662.
5. Bosch, M. L., A. C. Andeweg, R. Schipper, and M. Kenter. 1994. Insertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type 1 gp120 alters cellular tropism. J. Virol. 68:7566-7569.
6. Buchacher, A., R. Predl, K. Strutzenberger, W. Steinfellner, A. Trkola, M. Purtscher, G. Gruber, C. Tauer, F. Steinndl, A. Jungbauer, and H. Kattinger. 1994. Electrofusion and EBV transformation for PBL immortalization; generation of human monoclonal antibodies against HIV-1 proteins. AIDS Res. Hum. Retroviruses 10:359-369.
7. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988. Biologic features of HIV-1 that correlate with virulence in the host. Science 240:80-82.
8. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1992. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-6554.
9. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. MacKay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The B chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
10. Clapham, P. R., A. McKnight, and R. A. Weiss. 1992. Human immunodeficiency virus type 2 infection and fusion of CD4-negative cell lines: induction and enhancement by soluble CD4. J. Virol. 66:3531-3537.
11. Clavel, F., and P. Chameau. 1994. Fusion from without directed by human immunodeficiency virus particles. J. Virol. 68:1179-1185.
12. Clements, G. J., M. J. Price-Jones, P. E. Stephens, C. Sutton, T. F. Schulz, P. R. Clapham, J. A. McKeating, M. O. McClure, S. Thomson, M. Marsh, J. Kay, R. A. Weiss, and J. P. Moore. 1991. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion. AIDS Res. Hum. Retroviruses 7:3-16.
13. Conley, A. J., J. A. Kessler II, L. J. Boots, J.-S. Tung, B. A. Arnold, P. M. Keller, A. R. Shaw, and E. A. Emini. 1994. Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-412-2F5, an anti-sp41 human monoclonal antibody. Proc. Natl. Acad. Sci. USA 91:3348-3352.
14. Connor, R. I., and D. D. Ho. 1994. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:4400-4408.
15. Cornelissen, M., E. Hogervorst, F. Zorgdrager, S. Hartman, and J. Goudsmit. 1995. Maintenance of syncytium inducing phenotype of HIV type-1 is associated with positively charged residues in the HIV type-1 gp120 V2 domain without fixed positions, elongation, or relocated n-linked glycosylation sites. AIDS Res. Hum. Retroviruses 11:1169-1175.
16. Dalgleish, A. G., P. C. L. Beverly, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-767.
17. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major coreceptor for primary isolates of HIV-1. Nature 381:661-666.
18. Doranz, B. J., R. Rucker, Y. Yi, R. J. Smyth, S. Samson, S. C. Peiper, M. Parmentier, R. C. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the B-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
19. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
20. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV entry factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
21. Fenouillet, E., and I. M. Jones. 1995. The glycosylation of human-immuno-deficiency virus type-1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. J. Gen. Virol. 76:1509-1514.
22. Fenyo, E. M. 1993. Viral phenotype and severity of HIV-1 infection: are children different from adults? AIDS 7:1673-1674.
23. Freed, E. O., and M. A. Martin. 1994. Evidence for a functional interaction between the VI/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. J. Virol. 68:2503-2512.
24. Gartner, S., P. Markovits, D. Markovitz, M. Kaplan, R. Gallo, and M. Popovic. 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219.
25. Golding, H., D. S. Dimitrov, J. Manischewitz, C. C. Broder, J. Robinson, S. Fabian, D. R. Littman, and C. K. Lapham. 1995. Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules. J. Virol. 69:6140-6148.
26. Groenink, M., R. A. M. Fouchier, S. Broersen, C. H. Baker, M. Koot, A. B. Vantwout, H. G. Huisman, F. Miedema, M. Tersmette, and H. Schuite-maker. 1993. Relationship of phenotype evolution of HIV-1 to envelope V2 configuration. Science 260:1513-1516.
27. Hwang, S. S., T. J. Boyle, H. K. Lyerly, and B. R. Cullen. 1992. Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science 257:535-537.
28. Jeffs, S. A., J. McKeating, S. Lewis, H. Craft, D. Biram, P. E. Stephens, and R. L. Brady. 1996. Antigenicity of truncated forms of the HIV-1 glycoprotein. J. Gen. Virol 77:1403-1410.
29. Jones, A. Personal communication.
30. Karlsson, A., A. Parsmyr, E. Sandstrom, E. M. Fenyo, and J. Albert. 1994. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J. Clin. Microbiol. 32:364-370.
31. Keller, R., K. Peden, S. Paulous, L. Montagnier, and A. Cordonnier. 1993. Amino acid changes in the fourth conserved region of human immunodeficiency virus type-2 strain (Rod) envelope glycoprotein modulate fusion. J. Virol. 67:6253-6258.
32. Klatzmann, D., E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J. C. Gluckman, and L. Montagnier. 1984. T lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767-768.
33. Koenig, S., H. Gendelam, J. Orenstein, M. DalCanto, G. Pezeshkpour, M. Yungbluth, F. Janotta, A. Aksamit, M. Martin, and A. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS pateints with encephalopathy. Science 233:1089-1092.
34. Koito, A., L. Stamatatos, and C. Cheng-Mayer. 1995. Small amino-acid sequence changes within the V2 domain can affect the function of a T-cell line tropic human immunodeficiency virus type 1 envelope gp120. Virology 206:880-884.
35. Korber, B., and G. Myers. 1992. Signature pattern analysis: a method for assessing viral sequence relatedness. AIDS Res. Hum. Retroviruses 8:1549-1560.
36. Lamers, S. L., J. W. Sleasman, J. X. She, K. A. Barrie, S. M. Pomeroy, D. J. Barrett, and M. M. Goodenow. 1993. Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo. J. Virol. 67:3951-3960.
37. Lee, W. R., W. J. Syu, M. Essex, and T. H. Lee. 1992. Non-random distribution of gp120 N-linked glycosylation sites critical for HIV-1 infectivity. AIDS Res. Hum. Retroviruses 8:917.
38. Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type I recombinant human immunodeficiency virus envelope glycoprotein expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:10373-10382.
39. Li, Y., L. Z. Luo, N. Rasool, and C. Y. Kang. 1993. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J. Virol. 67:584-588.
40. McKeating, J. A., C. Shotton, J. Cordell, S. Graham, P. Balfe, N. Sullivan, M. Charles, M. Page, A. Bolmstedt, S. Olofsson, S. C. Kayman, Z. Wu, A. Pinter, C. Dean, J. Sodroski, and R. A. Weiss. 1993. Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120. J. Virol. 67:4932-4944.
41. Modrow, S., B. H. Hahn, G. M. Shaw, R. C. Gallo, F. Wong-Staal, and H. Wolf. 1987. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J. Virol. 61:570-578.
42. Moore, J. P., L. C. Burkly, R. I. Connor, Y. Cao, R. Tizard, D. D. Ho, and P. A. Fisher. 1993. Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the response of their envelope glycoproteins to soluble CD4. AIDS Res. Hum. Retroviruses 9:529-539.
43. Moore, J. P., and J. Sodroski. 1996. Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J. Virol. 70:1863-1872.
44. Moore, J. P., M. Thali, B. A. Jameson, F. Vignaux, G. K. Lewis, S. W. Poon, M. Charles, M. S. Fung, B. Sun, P. J. Durda, L. Akerblom, B. Wahren, D. D. Ho, Q. J. Sattentau, and J. Sodoroski. 1993. Immunochemieal analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domain and interaction of the C4 domain with the V3 loop. J. Virol. 67:4785-4796.
45. Moore, J. P., R. L. Willey, G. K. Lewis, J. Robinson, and J. Sodroski. 1994. Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1. J. Virol. 68:6836-6847.
46. Murphy, A. L., J. Lewis, J. Albert, P. Balfe, and J. A. McKeating. Antigenic variation within the CD4 receptor binding site of primary human immunodeficiency virus type 1 gp120 proteins. Submitted for publication.
47. Palmer, C., P. Balfe, D. G. Fox, J. C. May, R. Fredriksson, E. M. Fenyo, and J. A. McKeating. 1996. Functional characteristics of the V1V2 region of human immunodeficiency virus type 1. Virology 220:436-449.
48. Pollard, S. R., M. D. Rosa, J. J. Rosa, and D. C. Wiley. 1992. Truncated variants of gp120 bind CD4 with high-affinity and suggest a minimum CD4 binding region. EMBO J. 11:585-591.
49. Schuitemaker, H., R. A. M. Fouchier, S. Broersen, M. Groenink, M. Koot, A. B. van't Wout, H. G. Huisman, M. Tersmette, and F. Miedema. 1995. Envelope V2 configuration and HIV-1 phenotype: clarification. Science 268:115.
50. Schuitemaker, H., M. Koot, N. A. Koostra, M. W. Dercksen, R. E. De Goede, R. P. van Steenwijk, J. M. Lange, J. K. M. E. Schattenkerk, F. Miedema, and M. Tersmette. 1996. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is asso- ciated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1354-1360.
51. Shioda, T., J. A. Levy, and C. Cheng-Mayer. 1992. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell line and macrophage tropism of human immunodeficiency virus type-1. Proc. Natl. Acad. Sci. USA 89:9434-9438.
52. Shotton, C., C. Arnold, Q. J. Sattentau, J. Sodroski, and J. A. McKeating. 1995. Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 69:222-230.
53. Sullivan, N., M. Thali, C. Furman, D. D. Ho, and J. Sodroski. 1993. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. J. Virol. 67:3674-3679.
54. Tersmette, M., R. A. Gruters, D. F. Wolf, R. E. de Goede, J. M. Lange, P. T. Schellekens, J. Goudsmit, H. G. Huisman, and F. Miedema. 1989. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63:2118-2125.
55. Tersmette, M., J. M. A. Lange, R. E. De Goede, F. De Wolf, J. K. M. E. Schattenkerk, P. T. Schellekens, R. Coutinho, J. G. Huisman, J. Goudsmit, and F. Miedema. 1989. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet i:983-985.
56. Wang, N., T. F. Zhu, and D. D. Ho. 1995. Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype. J. Virol. 69:2708-2715.
57. Wang, W. K., M. Essex, and T. H. Lee. 1995. The highly conserved aspartic acid residue between hypervariable region 1 and region 2 of human immunodeficiency virus type 1 gp120 is important for early stages of virus replication. J. Virol. 69:538-542.
58. Wang, W. K., M. Essex, and T. H. Lee. 1996. Single amino acid substitution in constant region one or four of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revert. J. Virol. 70:607-611.
59. Willey, R. L., and M. A. Martin. 1993. Association of human immunodeficiency virus type 1 envelope glycoprotein with particles depends on interactions between the third variable and conserved regions of gp120. J. Virol. 67:3639-3643.
60. Willey, R. L., T. S. Theodore, and M. A. Martin. 1994. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. J. Virol. 68:4409-4419.
61. Wrin, T., T. P. Loh, J. C. Vennari, H. Schuitemaker, and J. H. Nunberg. 1995. Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol. 69:39-48.
62. Wu, Z., S. C. Kayman, W. Honnen, K. Revesz, H. Chen, S. Vijhwarrier, S. A. Tilley, J. McKeating, C. Shotton, and A. Pinter. 1995. Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain. J. Virol. 69:2271-2278.
63. Wyatt, R., J. Moore, M. Accola, E. Desjardin, J. Robinson, and J. Sodroski. 1995. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J. Virol. 69:5723-5733.
64. Wyatt, R., M. Thali, S. Tilley, A. Pinter, M. Posner, D. Ho, J. Robinson, and J. Sodroski. 1992. Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4-binding site in the fourth conserved region. J. Virol. 66:6997-7004.